Azurity Pharmaceuticals Inc

02/07/2022 | Press release | Archived content

AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF FLEQSUVYTM

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Azurity Pharmaceuticals Inc published this content on February 07, 2022, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 07, 2026 at 13:13 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]